...
首页> 外文期刊>AIDS Research and Human Retroviruses >A Retrospective Cohort Study on the Mortality of AIDS Patients in Guangxi, China (2001-2011)
【24h】

A Retrospective Cohort Study on the Mortality of AIDS Patients in Guangxi, China (2001-2011)

机译:中国广西艾滋病患者死亡率回顾性队列研究(2001-2011)

获取原文
获取原文并翻译 | 示例

摘要

The purpose of this article is to describe mortality trends in different highly active antiretroviral therapy (HAART) periods and associated factors among AIDS patients in Guangxi, China. We prospectively analyzed AIDS patients in Guangxi between 2001 and 2011; demographic characteristics were compared among AIDS patients diagnosed in three treatment periods (pre-HAART: 2001-2004, early-HAART: 2005-2008, and late-HAART: 2009-2011). AIDS mortality was calculated by person-years, and treatment coverage was defined as the proportion of time that patients who were eligible for treatment received treatment. Factors of AIDS mortality were determined by a Cox proportional hazard regression. Of 19,020 AIDS patients, overall mortality declined from 41.1 per 100 person-years in 2001 to 13.3 per 100 person-years in 2011 with treatment coverage increasing from zero to 72.1%. The overall median survival figure was 5.6 years (95% CI: 4.4-6.8) with 60.3% for 5-year survival rate. After AIDS diagnosis, the mortality rate peaked in the first year, and 37.4% patients were still active in the ninth year. Protective factors for mortality were AIDS patients diagnosed from 2009 to 2011 (AHR=0.75, 95% CI: 0.58-0.89), having received HAART (AHR=0.71, 95% CI: 0.50-0.87), and having a CD4 count of higher than 350 cells/mu l at AIDS diagnosis (AHR=0.79, 95% CI: 0.60-0.92). Risk factors for mortality included being male (AHR=1.28, 95% CI: 1.07-1.43), living in a rural area (AHR=1.40, 95% CI: 1.18-1.94), and being aged >= 60 years at AIDS diagnosis (AHR=1.36, 95% CI: 1.18-1.73). A decline in AIDS mortality was observed in Guangxi with a concomitant increase in treatment coverage. Some subpopulations of AIDS patients, such as males, rural residents, and the old, require more medical care.
机译:本文的目的是描述中国广西艾滋病患者在不同的高效抗逆转录病毒疗法(HAART)期间的死亡率趋势及其相关因素。我们对2001年至2011年广西的艾滋病患者进行了前瞻性分析。比较了在三个治疗阶段(HAART之前:2001-2004,HAART早期:2005-2008和HAART晚期:2009-2011)诊断出的艾滋病患者的人口统计学特征。艾滋病死亡率按人年计算,治疗覆盖率定义为符合治疗条件的患者接受治疗的时间比例。通过Cox比例风险回归确定AIDS死亡率的因素。在19,020名AIDS患者中,总死亡率从2001年的每100人年41.1下降到2011年的每100人年13.3,治疗覆盖率从零增加到72.1%。总体中位生存期为5.6年(95%CI:4.4-6.8),其中5年生存率为60.3%。艾滋病确诊后,死亡率在第一年达到峰值,而在第九年,仍有37.4%的患者活跃。死亡率的保护因素是2009年至2011年确诊的AIDS患者(AHR = 0.75,95%CI:0.58-0.89),接受过HAART(AHR = 0.71,95%CI:0.50-0.87),CD4计数更高在AIDS诊断中超过350个细胞/μl(AHR = 0.79,95%CI:0.60-0.92)。死亡的危险因素包括男性(AHR = 1.28,95%CI:1.07-1.43),居住在农村地区(AHR = 1.40,95%CI:1.18-1.94),以及在诊断艾滋病时年龄≥60岁(AHR = 1.36,95%CI:1.18-1.73)。在广西观察到艾滋病死亡率下降,同时治疗覆盖率增加。一些艾滋病患者群体,例如男性,农村居民和老年人,需要更多的医疗服务。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号